Intravenous administration is more likely to increase plasma carnitine concentration, yet homeostatic mechanisms tightly control blood concentration through metabolism and renal excretion: Up to 90% of 2 g of L-carnitine administered intravenously is excreted into the urine within 12 to 24 hours
April 24, 2026 Cagrilintide sourcing guide covering supplier evaluation for a lipidated long acting amylin analog and the Midwest Peptide research catalog
FDA-approved anti-obesity medications fall into several categories, and Medicaid coverage, where it exists, does not necessarily extend to all of them
Both BPC-157 and TB-500 are peptides, which are short chains of amino acids
Researchers are already testing triple-agonist drugs, such as retatrutide, which target GLP-1, GIP and glucagon receptors